Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
15°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Havn Life Sciences Inc
(OP:
HAVLF
)
0.0052
UNCHANGED
Streaming Delayed Price
Updated: 11:40 AM EST, Nov 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Havn Life Sciences Inc
< Previous
1
2
Next >
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
July 31, 2024
Jamaica introduces its first legal psilocybin products in pharmacies through a historic partnership between PATOO and Fontana Pharmacy.
Via
Benzinga
HAVN Life Closes First Tranche Of July Financing By ABO, Details On Amendments And Debt Shares Issuance
August 19, 2022
Biotech psychedelics company HAVN Life Sciences Inc. (OTC: HAVLF) recently closed the initial tranche of its financing pact with innovative fund Alpha Blue Ocean (“ABO”), previously announced on July...
Via
Benzinga
Learn About HAVN Life's New Shares Consolidation, What Changes And What Remains
August 01, 2022
A key player in the biotech-meets-psychedelics space, HAVN Life Sciences Inc.
Via
Benzinga
HAVN Life Sciences & Optimi Health Corp Announce Supply Agreements, Here Are The Details
June 28, 2022
Two publicly traded psychedelics companies announced supply agreements. HAVN Life Sciences (OTC: HAVLF) will provide mental health clinic MPB Group Inc. with psilocybin-containing mushrooms for its...
Via
Benzinga
HAVN Life Sciences Inc. to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022
April 30, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
HAVN Life Sciences Inc.
Via
AccessWire
HAVN Life Sciences (CSE: HAVN) (OTC: HAVLF) Featured in Coverage of Planet MicroCap’s Virtual Investor Conference
April 14, 2022
Via
Investor Brand Network
Topics
Economy
Exposures
Supply Chain
HAVN Life Sciences (HAVLF) Featured in Coverage of Investor Summit Group’s Q1 Virtual Event
March 07, 2022
Via
Investor Brand Network
Topics
Economy
Exposures
Supply Chain
Psyched: Cathie Wood Invests In Psychedelics Co ATAI, Bill Approved in Utah, AI Startup To 'Design States Of Mind'
February 14, 2022
The psychedelics sector received its latest sign of acceptance from Wall Street with famed investor Cathie Wood taking a position ...
Via
Benzinga
HAVN Life Enters Distribution Agreement With Mycrodose Therapeutics For U.S. Market
February 10, 2022
HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP), a biotechnology company working with psychedelic compounds for investigational research to support brain health and cognitive function,...
Via
Benzinga
Havn Life Buys Subscription-Based Functional Mushroom Co. With Significant US Consumer Base
December 20, 2021
Biotech company Havn Life Sciences Inc. (CSE:HAVN) (OTC: HAVLF) is purchasing functional mushroom wellness brand Spore Life Sciences Inc. The Deal Details Under the deal...
Via
Benzinga
HAVN Life Successfully Exports Naturally Derived Psilocybin From Its Jamaica Facility Into Canada
November 23, 2021
Demonstrating the integrity of its supply chain from Jamaica into Canada, biotechnology company HAVN Life Sciences (OTCPK: HAVLF) achieved a milestone with...
Via
Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
The Week In Psychedelics
Via
Benzinga
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021
December 06, 2021
LOS ANGELES, CA / ACCESSWIRE / December 6, 2021 / The SNN Network Canada Virtual Event will take place on December 7-9, 2021, where 70 SmallCap, MicroCap and NanoCap public and private companies will...
From
Stock News Now
Via
AccessWire
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...
Via
Benzinga
Former Tilray CEO Joins Psychedelics Company
October 07, 2021
More big names in cannabis are switching to psychedelics. Greg Engel, former CEO of Tilray (NASDAQ:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) Featured in Virtual Coverage of LD Micro’s Main Event
October 01, 2021
Via
Investor Brand Network
Psyched: Delic Buys 10 Ketamine Clinics For $10M, Atai Launches Ibogaine Human Trials, Small Pharma Concludes Phase 1 DMT Study
September 27, 2021
The Week In Psychedelics:
Via
Benzinga
HAVN Life Announces Supply and Distribution MOU with Mycrodose Therapeutics
September 23, 2021
The partnership is a integral step in the The Company's path to market in the U.S., achieving one of its most important milestones to-date VANCOUVER, BC / ACCESSWIRE / September 23, 2021 / Havn Life...
From
Havn Life Sciences Inc.
Via
AccessWire
Exposures
Product Safety
HAVN Life Announces Distribution Deal with Horizon Grocery + Wellness
September 21, 2021
VANCOUVER, BC / ACCESSWIRE / September 21, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of...
From
Havn Life Sciences Inc.
Via
AccessWire
Topics
Supply Chain
Exposures
Supply Chain
Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics
September 13, 2021
Last Week In Psychedelics:
Via
Benzinga
Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
August 30, 2021
Contents
Via
Benzinga
HAVN Life Signs Agreement to Supply Psilocybin for Mycotopia Therapies
August 25, 2021
The partnership will further industry growth for naturally derived psilocybin VANCOUVER, BC / ACCESSWIRE / August 25, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company"...
From
Havn Life Sciences Inc.
Via
AccessWire
HAVN Life Harvests First Crop of Psilocybin Mushrooms at its Jamaica Facility
August 03, 2021
HAVN Life will export to Delic Labs in Canada for quality control and testing. This makes HAVN Life the first in the Caribbean Community and Common Market to export psilocybin. VANCOUVER, BC /...
From
Havn Life Sciences Inc.
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected
August 02, 2021
Last week in Psychedelics:
Via
Benzinga
HAVN Life Natural Health Products Now Available on Amazon.ca
July 29, 2021
With FBA designation, the Company continues to grow its retail footprint by partnering with the world's largest ecommerce site VANCOUVER, BC / ACCESSWIRE / July 29, 2021 / Havn Life Sciences Inc....
From
Havn Life Sciences Inc.
Via
AccessWire
HAVN Life Signs Agreement to Enable Export of Psilocybin into Canada, the US and Europe
July 27, 2021
The Agreement with P.A. Benjamin Manufacturing Company whom operates a GMP compliant facility in Jamaica VANCOUVER, BC / ACCESSWIRE / July 27, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC...
From
Havn Life Sciences Inc.
Via
AccessWire
How To Invest In "Magic Mushrooms" (Psychedelics)
July 09, 2021
A look at psychedelics as stock market investment opportunities and identifying alternative strategies on how to invest.
Via
Talk Markets
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021
July 08, 2021
RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13th - 15th, 2021. More than 50 companies are...
From
Access to Giving
Via
AccessWire
HAVN Life Signs Exclusive Supply Agreement With Cube Psytech
July 08, 2021
The Company will supply naturally-derived psilocybin for the development of psilocybin microdosing health products VANCOUVER, BC / ACCESSWIRE / July 8, 2021 / Havn Life Sciences Inc. (CSE:HAVN) (OTC...
From
Havn Life Sciences Inc.
Via
AccessWire
HAVN Life Sciences Signs Finished Goods Supply Agreement with Allied Health
June 29, 2021
The Agreement will utilize HAVN Life's fully integrated supply chain model, from the growing of psilocybin through to extraction, compounding, and encapsulation VANCOUVER, BC / ACCESSWIRE / June 29,...
From
Havn Life Sciences Inc.
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.